Skip to main content

Published locations for Basiliximab/BEAM may improve post-ASCT outcomes in PTCL

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Basiliximab/BEAM may improve post-ASCT outcomes in PTCL

User login

  • Reset your password
  • /content/basiliximab/beam-may-improve-post-asct-outcomes-ptcl
  • /hematologynews/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct-outcomes-ptcl
  • /jcso/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct-outcomes-ptcl
  • /oncologypractice/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct-outcomes
  • /hematologynews/nhlhub/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct
  • /hematology-oncology/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct-outcomes
  • /b-cell-lymphoma-icymi/article/159194/t-cell-lymphomas/basiliximab/beam-may-improve-post-asct